Andrew V. Schally, MD, PhD
Affiliations: | 1957-1962 | Physiology | Baylor College of Medicine, Houston, TX |
1962- | Endocrinology | Tulane Medical School, New Orleans, LA, United States |
Area:
EndocrinologyWebsite:
http://www.nobelprize.org/nobel_prizes/medicine/laureates/1977/schally-bio.htmlGoogle:
"Andrew V. Schally"Bio:
The Nobel Prize in Physiology or Medicine 1977 was divided, one half jointly to Roger Guillemin and Andrew V. Schally for their discoveries concerning the peptide hormone production of the brain
and the other half to Rosalyn Yalow for the development of radioimmunoassays of peptide hormones
.
Dissertation: https://mcgill.on.worldcat.org/oclc/820538950
http://www.nasonline.org/member-directory/members/50830.html
Mean distance: 19.27 (cluster 7) | S | N | B | C | P |
Cross-listing: Chemistry Tree
Parents
Sign in to add mentorMurray Saffran | grad student | 1957 | McGill | |
(In vitro studies on the control of the release of ACTH.) | ||||
Roger Guillemin | post-doc | Baylor College of Medicine |
Children
Sign in to add traineeIgnacio Torres-Aleman | grad student | ||
Abba J. Kastin | research scientist | 1964- | Tulane Medical School |
Collaborators
Sign in to add collaboratorJames Lamar Wittliff | collaborator | Tulane University (Chemistry Tree) | |
Roger Guillemin | collaborator | 1957-1962 | Baylor College of Medicine |
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Granata R, Leone S, Zhang X, et al. (2024) Author Correction: Growth hormone-releasing hormone and its analogues in health and disease. Nature Reviews. Endocrinology |
Granata R, Leone S, Zhang X, et al. (2024) Growth hormone-releasing hormone and its analogues in health and disease. Nature Reviews. Endocrinology |
Gesmundo I, Pedrolli F, Cai R, et al. (2024) Growth hormone-releasing hormone and cancer. Reviews in Endocrine & Metabolic Disorders |
Gesmundo I, Granato G, Fuentes-Fayos AC, et al. (2021) Antagonists of Growth Hormone-Releasing Hormone Inhibit the Growth of Pituitary Adenoma Cells by Hampering Oncogenic Pathways and Promoting Apoptotic Signaling. Cancers. 13 |
Barabutis N, Akhter MS, Uddin MA, et al. (2020) GHRH Antagonists Protect Against Hydrogen Peroxide-Induced Breakdown of Brain Microvascular Endothelium Integrity. Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme. 52: 336-339 |
Recinella L, Chiavaroli A, Orlando G, et al. (2020) Publisher Correction: Antinflammatory, antioxidant, and behavioral effects induced by administration of growth hormone-releasing hormone analogs in mice. Scientific Reports. 10: 4850 |
Uddin MA, Akhter MS, Singh SS, et al. (2019) GHRH antagonists support lung endothelial barrier function. Tissue Barriers. 1669989 |
Zhang C, Cai R, Lazerson A, et al. (2019) Growth Hormone-Releasing Hormone Receptor Antagonist Modulates Lung Inflammation and Fibrosis due to Bleomycin. Lung |
Villanova T, Gesmundo I, Audrito V, et al. (2019) Antagonists of growth hormone-releasing hormone (GHRH) inhibit the growth of human malignant pleural mesothelioma. Proceedings of the National Academy of Sciences of the United States of America |
Schally AV, Wang H, He J, et al. (2018) Agonists of growth hormone-releasing hormone (GHRH) inhibit human experimental cancers in vivo by down-regulating receptors for GHRH. Proceedings of the National Academy of Sciences of the United States of America |